# Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer

> **NCT00408070** · PHASE2 · TERMINATED · sponsor: **UConn Health** · enrollment: 5 (actual)

## Conditions studied

- Ovarian Cancer
- Peritoneal Cancer
- Fallopian Tube Cancer
- Stage 3 Cancer
- Stage 4 Cancer

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00408070
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2009-08
- **Final completion:** 2009-10
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Did not meet accrual goals.
- **Last updated:** 2018-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408070, "Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00408070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*